Peter B. Coggins
Direktor/Vorstandsmitglied bei BIOSEEK PLC
Aktive Positionen von Peter B. Coggins
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| BIOSEEK PLC | Direktor/Vorstandsmitglied | 03.04.2008 | - |
| Independent Dir/Board Member | 03.04.2008 | - |
Karriereverlauf von Peter B. Coggins
Ehemalige bekannte Positionen von Peter B. Coggins
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| Amersham Biosciences Corp. /One Dimen Electrophoresis Bus/ | Vertrieb & Marketing | 01.01.1994 | 01.06.2002 |
NIPD Genetics Ltd.
 NIPD Genetics Ltd. BiotechnologyHealth Technology Part of Medicover AB, NIPD Genetics Ltd. is a Cypriot biotechnology company. The company is based in Nicosia, Cyprus. The company was founded in 2010 by Philippos C. Patsalis. Philippos C. Patsalis has been the CEO since 2010. NIPD Genetics was acquired by Medicover AB on January 18, 2022 for $50.32 million. | Direktor/Vorstandsmitglied | - | - |
| Analytical Life Science & Diagnostics Association | Vorsitzender | - | - |
deltaDOT Ltd.
 deltaDOT Ltd. Medical SpecialtiesHealth Technology deltaDOT Ltd. develops and commercializes technologies for the separation and analysis of biomolecules. It offers High Performance Capillary Electrophoresis and Conventional Capillary Electrophoresis, and analytical services and contract research. The company was founded by Stuart Hassard and John Hassard in 2000 and is headquartered in London, the United Kingdom. | Direktor/Vorstandsmitglied | - | - |
| REVVITY, INC. | Corporate Officer/Principal | 01.07.2002 | - |
Ausbildung von Peter B. Coggins
| Chelsea College | Doctorate Degree |
Statistik
International
| Vereinigte Staaten | 4 |
| Vereinigtes Königreich | 4 |
| Zypern | 2 |
Operativ
| Director/Board Member | 3 |
| Corporate Officer/Principal | 1 |
| Sales & Marketing | 1 |
Sektoral
| Health Technology | 5 |
| Commercial Services | 2 |
| Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| REVVITY, INC. | Health Technology |
| Private Unternehmen | 5 |
|---|---|
| Amersham Biosciences Corp. /One Dimen Electrophoresis Bus/ | Health Technology |
deltaDOT Ltd.
deltaDOT Ltd. Medical SpecialtiesHealth Technology deltaDOT Ltd. develops and commercializes technologies for the separation and analysis of biomolecules. It offers High Performance Capillary Electrophoresis and Conventional Capillary Electrophoresis, and analytical services and contract research. The company was founded by Stuart Hassard and John Hassard in 2000 and is headquartered in London, the United Kingdom. | Health Technology |
BioSeek Plc
 BioSeek Plc Miscellaneous Commercial ServicesCommercial Services BioSeek Plc provides human tissue-based research services for the pharmaceutical industry. It focuses on applying human primary cell assays and predictive disease models to the discovery and development of human therapeutics and safer chemicals. The company was founded by Eugene Butcher in March 1996 and is headquartered in London, the United Kingdom. | Commercial Services |
| Analytical Life Science & Diagnostics Association | |
NIPD Genetics Ltd.
NIPD Genetics Ltd. BiotechnologyHealth Technology Part of Medicover AB, NIPD Genetics Ltd. is a Cypriot biotechnology company. The company is based in Nicosia, Cyprus. The company was founded in 2010 by Philippos C. Patsalis. Philippos C. Patsalis has been the CEO since 2010. NIPD Genetics was acquired by Medicover AB on January 18, 2022 for $50.32 million. | Health Technology |
- Börse
- Insiders
- Peter B. Coggins
- Erfahrung
